Morgan Stanley’s Markforged Holding Corporation Warrants, each whole warrant exercisable to purchase one-tenth (1/10th) of a share of Common Stock at an exercise price of $115.00 per share MKFG.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-124
Closed 8178
2021
Q4
$0 Hold
124
﹤0.01% 8158
2021
Q3
$0 Buy
+124
New +$200 ﹤0.01% 8060

Other funds holding MKFG.WS

Morgan Stanley's MKFG.WS Position: Q1 2022 in Review

Morgan Stanley sold out of Markforged Holding Corporation Warrants, each whole warrant exercisable to purchase one-tenth (1/10th) of a share of Common Stock at an exercise price of $115.00 per share (MKFG.WS) in Q1 2022, closing a stake of 124 shares.

Morgan Stanley first reported a position in MKFG.WS in Q3 2021 and held it in 2 quarters. The position peaked at $0 in Q4 2021. 18 funds tracked by Wall St. Rank hold MKFG.WS as of Q1 2022.

  • Morgan Stanley reported no remaining Markforged Holding Corporation Warrants, each whole warrant exercisable to purchase one-tenth (1/10th) of a share of Common Stock at an exercise price of $115.00 per share position as of Q1 2022 after selling out during the quarter.
  • Morgan Stanley sold 124 Markforged Holding Corporation Warrants, each whole warrant exercisable to purchase one-tenth (1/10th) of a share of Common Stock at an exercise price of $115.00 per share shares in Q1 2022.
  • Morgan Stanley first reported a position in Markforged Holding Corporation Warrants, each whole warrant exercisable to purchase one-tenth (1/10th) of a share of Common Stock at an exercise price of $115.00 per share in Q3 2021 and held it in 2 quarters.
  • Morgan Stanley's Markforged Holding Corporation Warrants, each whole warrant exercisable to purchase one-tenth (1/10th) of a share of Common Stock at an exercise price of $115.00 per share position peaked at $0 in Q4 2021.
  • 18 funds tracked by Wall St. Rank held Markforged Holding Corporation Warrants, each whole warrant exercisable to purchase one-tenth (1/10th) of a share of Common Stock at an exercise price of $115.00 per share as of Q1 2022.

Based on Morgan Stanley's 13F filing for Q1 2022, filed 13 May 2022.